MDWK.OQBMdwerks, INC

Form 4: MDWerks Director Brocopp Acquires 65,325 Shares

Sentiment:

Insider Transaction Report


MDWerks Director Timothy Brocopp acquired 65,325 shares of common stock at $0.153 per share as part of his employment agreement.

Summary

  • Timothy Brocopp, a Director of MDWerks, Inc. (MDWK), acquired 65,325 shares of common stock.
  • The transaction occurred on November 13, 2025, at a price of $0.153 per share.
  • This acquisition increases Brocopp's direct beneficial ownership to 2,990,677 shares.
  • The shares were granted on a quarterly basis as per an employment agreement dated November 18, 2024, and approved by the board of directors in accordance with Rule 16b-3.

Sentiment

Score: 7

Explanation: The filing indicates a routine, pre-planned equity grant to a director, which is generally positive for aligning interests but does not suggest significant new developments or immediate catalysts. The increase in insider ownership is a mild positive.

Positives

  • An insider, Timothy Brocopp, increased his direct beneficial ownership in MDWerks, Inc. by 65,325 shares, signaling continued alignment with shareholder interests.
  • The share grant is part of a pre-existing employment agreement, indicating a structured and approved compensation plan for a key director.

Negatives

  • The transaction price of $0.153 per share is relatively low, which could reflect the company's current valuation or the nature of the compensation grant.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This transaction is a routine insider equity grant, common across industries as a form of executive compensation. It reflects the company's commitment to aligning director incentives with long-term shareholder value, a standard practice in corporate governance.

Comparison to Industry Standards

  • The grant of equity as part of an employment agreement is a standard practice for director compensation in publicly traded companies, aligning management interests with shareholder returns.
  • The specific value and frequency of such grants vary widely by company size, industry, and individual executive roles, making direct comparisons without more context difficult.
  • The approval by the board of directors and compliance with Rule 16b-3 are standard governance practices for such transactions.

Related Party Transactions

  • The grant of shares is pursuant to an Employment Agreement entered into between Reporting Person Timothy Brocopp (a Director) and the Issuer, MDWerks, Inc., which constitutes a related party transaction.

Stakeholder Impact

  • Shareholders: Increased alignment of a director's interests with shareholders due to increased equity ownership.
  • Management: Timothy Brocopp's compensation structure includes equity, incentivizing long-term performance.

Next Steps

  • Continued quarterly grants of common stock to Timothy Brocopp as per the employment agreement.

Key Dates

DateDescription
11/18/2024Date of Employment Agreement between Timothy Brocopp and MDWerks, Inc.
11/13/2025Date of common stock acquisition by Timothy Brocopp.
12/09/2025Date the Form 4 was signed by Timothy Brocopp.

Recommendation

hold

This Form 4 reports a routine, pre-scheduled equity grant to a director as part of an existing employment agreement. While an increase in insider ownership is generally a positive signal of alignment, this specific transaction is not indicative of new strategic developments or a change in the company's fundamental outlook that would warrant a change in investment recommendation. It's an expected event, thus a 'hold' recommendation is appropriate as it doesn't provide new information to alter a prior investment thesis.

Keywords

MDWerks, MDWK, Timothy Brocopp, Insider Trading, Form 4, Share Acquisition, Director Compensation, Equity Grant, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.